SIRT1 and hepatocellular carcinoma: To investigate the role of miR-124/SIRT1 axis in changing the sensitivity of CD133+ HCC cells to cisplatin, we transfected the CD133+ HepG2 and Huh7 cells with miR-124 and SIRT1 plasmid before treatment with cisplatin.